ClinicalTrials.Veeva

Menu

Efficacy of Virtual Reality Exercises on Sarcopenia in Patients With Liver Transplantation (LT)

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Sarcopenia

Treatments

Other: conventional treatment
Other: Virtual Reality exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT06209073
P.T.REC/012/003915

Details and patient eligibility

About

This study will be conducted to investigate the effect of virtual reality exercises on hand grip strength, pinch strength, quadriceps muscle strength, exercise capacity, fatigue, and quality of life in patients with liver transplantation.

Full description

Liver transplantation (LT) continues to prove to be the best choice for curing patients with end-stage liver disease (ESLD) . Management strategies in peri-transplantation care have significantly improved the outcomes of patients after LT. One of the most challenging tasks of LT is defining which patients are clinically appropriate for this therapy. Evaluating disease severity for patients with ESLD is a serious challenge for liver transplant surgeons, and there is a critical need for better methods of risk stratification. The most common complications involved include ascites, hepatic encephalopathy, and variceal bleeding; however, severe muscle wasting or sarcopenia is the most common and frequently undiagnosed complications that negatively impact survival, quality of life, and response to stressors, such as infections and surgeries. Virtual reality (VR) is an interactive, 3-dimensional computer experience occurring in real time. It allows the users to participate in multisensory and multidimensional virtual environments . It provides the participants with real-time auditory, visual, and proprioception sensory feedback. It also provides a safe virtual exercise environment. sixty patients with liver transplantation will be assigned randomly to two groups; experimental group will receive virtual reality exercise plus traditional therapy for six weeks, control group will receive traditional therapy alone for six weeks

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Sixty patients suffer from sarcopenia with liver transplantation. The age of patients ranges from (18:65) years. All patients must be conscious. Patients suffer from muscle weakness Patients suffer from fatigue Patients with low muscle endurance Patients' cases must be stable to deal with them

Exclusion criteria

Patients will be excluded if they have any of the following:

Any sign of acute rejection of the transplanted organ Acute hemorrhage Electrolyte imbalance Physiological instability Sever neurologic complication Sever cardiovascular co-morbidities

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

virtual reality exercise
Experimental group
Description:
the patients will receive virtual reality and conventional therapy three times a week for six weeks
Treatment:
Other: Virtual Reality exercise
Other: conventional treatment
conventional treatment
Experimental group
Description:
the patients will receive conventional treatment three times a week for six weeks
Treatment:
Other: conventional treatment

Trial contacts and locations

1

Loading...

Central trial contact

Nabil M Ismail, Assist. Prof; Sata A Elshrief, Bsc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems